Photoprotective Effects of a SPF50+ Sunscreen on Skin Genotoxicity Induced by Repeated Chronic Outdoor Sun Exposure

Sun Damaged Skin Clinical Trial

Official title: Evaluation of the Photoprotective Effects of a SPF50+ Sunscreen on Photo-induced Cell Damage in Epidermal and Urine Samples, Following a Repeated Chronic Outdoor Sun Exposure in Healthy Adults

Status Completed

Clinical Trial Summary

Between 2 and 3 million non-melanoma skin cancers and 132,000 melanoma skin cancers occur globally each year. Sun protection continues to be a major public health issue and has always been a priority research area for Pierre Fabre laboratories. The involvement of ultraviolet radiation of the solar spectrum in skin carcinogenesis is well known, through its ability to damage the DNA of skin cells and the induction of oxidative processes. The aim of this exploratory study is to perform the quantification of: - DNA photoproducts excised from the genome by the biological repair systems in urine samples - cellular DNA damage in the epidermis following chronic exposure to natural sunlight. This study will allow us to better understand and quantify the benefit of sunscreens on photoinduced cellular damage and their elimination in urine.

Clinical Trial Description

This trial is a monocentric, exploratory, randomized, controlled, open-label, parallel-group study conducted in healthy adult subjects. The target population consists of subjects who are accustomed to using few products or using low protection index during sun exposure. The study area is the whole body for sun exposure. The target areas are the face and forearms for the samplings and measurements. In this design, in order not to impose any strong constraint to the subjects in terms of sun exposure, the duration of the exposure period is left free and can vary between 5 and 21 days. Within this window, subjects can freely determine their sun exposure episodes (choice of time slot, number and duration). However, subjects have to expose themselves for at least 3 hours /day, for 5 days in the week prior to visit 2 (which will be scheduled no more than 3 days after their last sun exposure). The study includes 3 visits: - Visit 1: Inclusion (D1) - Visit 2: Intermediate visit (D7 to D39) - Visit 3: Wound healing evaluation and end of study (V2 + 15 days +/- 2 days) The period of outdoor sun exposure varies between 5 and 21 days depending on the duration planned by the subjects themselves. This is also the duration of application of the investigational product for the subjects in group 1. Visit 1 can be performed up to 15 days before the beginning of the sun exposure period and visit 2 up to 3 days after the last sun exposure. The duration of participation for a subject varies between 20 and 56 days (from inclusion to the end of the study). ;

Related Conditions & MeSH terms

• Sun Damaged Skin

• NCT number: NCT05926791
• Study type: Observational
• Source: Pierre Fabre Dermo Cosmetique
• Status: Completed
• Start date: June 28, 2021
• Completion date: September 13, 2021